Tagrisso

Tagrisso (osimertinib) is a prescription medication used to treat EGFR-positive non-small cell lung cancer. A once-daily pill for non-small cell lung cancer that has a specific EGFR mutation, used in several stages of the disease.

An EGFR tyrosine kinase inhibitor that blocks the mutated signal driving the cancer's growth.

Commonly reported side effects of Tagrisso include Diarrhea, Rash, Dry skin, Lung inflammation, and Heart rhythm and heart muscle problems. This is not a complete list — tell your doctor or pharmacist about any side effects you experience.

Tagrisso has notable warnings and precautions. Tell your doctor about your medical history and any other medicines or supplements you take before starting Tagrisso.

The active ingredient in Tagrisso is osimertinib, which belongs to a class of medicines known as EGFR Tyrosine Kinase Inhibitor.

Tagrisso is manufactured by AstraZeneca. It was first approved in 2015.

You may be able to lower the cost of Tagrisso by using a free pharmacy discount card or by comparing prices across pharmacies before you fill your prescription. Savings vary by pharmacy and location.